Press Releases | NeoGenomics Laboratories

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Presented: May 5, 2021

NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

Presented: May 5, 2021

NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

Presented: April 19, 2021

NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Patients

Presented: April 13, 2021

NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference

Presented: April 7, 2021

NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021

Presented: March 24, 2021

NeoGenomics Agrees to Acquire Trapelo Health

Presented: March 16, 2021

NeoGenomics and Elevation Oncology Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study

Presented: March 1, 2021

NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference

Presented: February 25, 2021

NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference

Presented: February 24, 2021

NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

Presented: February 24, 2021

NeoGenomics Announces CEO Succession